It was reported that PEPCK and SREBP-1c transgenic mice had severe hepatic steatosis, indicating histological steatosis but not steatohepatitis or dyslipidemia in the liver [22, 23]. The gene discussed is PCK2; the disease is Hepatic steatosis.